サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1794602

患者が作成した健康データの世界市場

Patient Generated Health Data

出版日
ページ情報
英文 277 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.53円
患者が作成した健康データの世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 277 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

患者が作成した健康データの世界市場は2030年までに75億米ドルに達する見込み

2024年に52億米ドルと推定される患者が作成した健康データの世界市場は、2024年から2030年にかけてCAGR 6.1％で成長し、2030年には75億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるフィットネス＆ウェルネスデータは、CAGR 8.0%を記録し、分析期間終了時には33億米ドルに達すると予測されます。疾病管理データ分野の成長率は、分析期間中CAGR 4.5%と推定されます。

米国市場は14億米ドル、中国はCAGR 10.0％で成長すると予測

米国の患者が作成した健康データ市場は、2024年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに16億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と6.1%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の患者が作成した健康データ市場- 主要動向と促進要因まとめ

患者が作成した健康データとは何か、なぜ臨床上の意思決定に有用なのか？

患者が作成した健康データ（PGHD）とは、ウェアラブル、モバイルアプリ、自己申告入力など、従来の臨床現場以外で個人が作成、記録、収集した健康関連データを指します。このデータには、症状、ライフスタイル行動、生体測定値、治療アドヒアランス、QOL指標に関する情報が含まれます。通院や検査で取得されるデータとは異なり、PGHDは患者の日々の健康状態に関する継続的でリアルタイムの洞察を提供します。

PGHDの使用は、特に慢性疾患管理と予防医療において、患者のモニタリングと個別化されたケアの提供に変革をもたらしつつあります。PGHDは臨床と臨床の間の重要なギャップを埋め、臨床医に患者の経過と行動のより総合的なビューを提供します。ヘルスケアがアウトカムベースのモデルへと移行する中、ケアプランにPGHDを取り入れることで、応答性、早期介入、患者と医療者の連携が改善されつつあります。

PGHDの収集と使用をサポートするデバイス、プラットフォーム、標準はどのように進化しているか？

技術の進歩により、PGHDの範囲、精度、使いやすさが向上しています。ウェアラブルデバイスは現在、心拍数、グルコースレベル、睡眠パターン、活動レベルを含む幅広いパラメーターを医療レベルの精度でモニターしています。スマートフォンのアプリケーションによって、ユーザーは薬の摂取量、気分、食習慣を追跡できるようになっています。音声認識ツールやスマートホームデバイスも、患者が使いやすい形式での受動的データ取得に貢献しています。

PGHDを臨床的に適切なものにするために、このデータを構造化された解釈可能なフォーマットで電子カルテに統合するためのプラットフォームが開発されています。標準化されたAPIとデータガバナンスフレームワークにより、データセキュリティ、相互運用性、同意管理が改善されつつあります。臨床アルゴリズムとダッシュボードは、医師のためにPGHDをフィルタリング、優先順位付け、視覚化するように設計されており、生データに圧倒されることなく意味のある変化に対応できるようになっています。

PGHDの採用はどこで拡大し、どの使用事例がアプリケーションをリードしているか？

PGHDの採用は、ヘルスケアシステム、ウェルネスプログラム、遠隔患者モニタリングサービス、臨床研究などで拡大しています。北米と欧州は、患者主導のデータ利用に対するインフラの準備と規制上のサポートでリードしています。アジア太平洋は、ウェアラブルや健康アプリがより安価になり、幅広い層が利用できるようになるにつれて、急速に追い上げています。

使用事例は、糖尿病、心血管疾患、メンタルヘルス、腫瘍学、呼吸器疾患などの疾患にわたって拡大しています。遠隔患者監視プログラムは、早期警告兆候を検出し、入院を減らすためにPGHDに依存しています。臨床試験では、患者報告アウトカムとリアルタイムのバイオメトリクスにより、データの正確性と参加者の維持率が向上しています。保険会社もPGHDを活用して、ウェルネス・インセンティブを調整し、リスク・プロファイルをより正確に評価しています。

患者が作成した健康データ市場の成長は、いくつかの要因によってもたらされます。

患者が作成した健康データ市場の成長は、ウェアラブル技術の採用の増加、個別化医療への注目の高まり、継続的な健康モニタリングに対する需要の高まりなどの要因によってもたらされます。センサーの小型化、モバイル接続性、健康追跡アルゴリズムの進歩により、さまざまな層で信頼性が高く使いやすいデータ収集が可能になりつつあります。

遠隔診療の払い戻しやデジタルカルテの統合を支援する規制の枠組みは、医療提供者が日常的なケア管理にPGHDを含めるよう促しています。慢性疾患のモニタリング、退院後のケア、ウェルネス・トラッキングは、PGHDにとって実用性の高い応用分野を生み出しています。患者の意識と自己管理行動の向上がデータの豊富さにさらに貢献しており、PGHDは集団健康分析、リスク層別化、プロアクティブ・ケア提供モデルの重要なインプットとなっています。

セグメント

データタイプ（フィットネス＆ウェルネスデータ、疾病管理データ、遠隔モニタリングデータ、その他のデータタイプ）、エンドユーザー（病院＆クリニックエンドユーザー、研究センターエンドユーザー、医療費支払者エンドユーザー、その他のエンドユーザー）

調査対象企業の例

  • AliveCor Inc.
  • Allscripts Healthcare Solutions
  • Apple Inc.
  • Athenahealth Inc.
  • Cerner Corporation
  • Dexcom Inc.
  • Epic Systems Corporation
  • Fitbit Inc.
  • HealthMine Inc.
  • Livongo Health（now part of Teladoc）
  • Medidata Solutions
  • Medtronic plc
  • Noom Inc.
  • Omada Health Inc.
  • PatientLikeMe
  • Propeller Health
  • WellDoc Inc.
  • Luscii（Omron）
  • Athelas
  • Kwido

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37677

Global Patient Generated Health Data Market to Reach US$7.5 Billion by 2030

The global market for Patient Generated Health Data estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Fitness & Wellness Data, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Disease Management Data segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.0% CAGR

The Patient Generated Health Data market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Patient Generated Health Data Market - Key Trends & Drivers Summarized

What Is Patient Generated Health Data and Why Is It Valuable in Clinical Decision Making?

Patient generated health data (PGHD) refers to health-related data created, recorded, or gathered by individuals outside traditional clinical settings, often through wearables, mobile apps, or self-reported inputs. This data includes information on symptoms, lifestyle behaviors, biometric readings, treatment adherence, and quality of life metrics. Unlike data captured during hospital visits or lab tests, PGHD provides continuous, real-time insights into a patient’s day-to-day health status.

The use of PGHD is transforming patient monitoring and personalized care delivery, particularly in chronic disease management and preventive health. It fills important gaps between clinical encounters, offering clinicians a more holistic view of patient progress and behavior. As healthcare moves toward outcome-based models, the inclusion of PGHD in care planning is improving responsiveness, early intervention, and patient-provider collaboration.

How Are Devices, Platforms, and Standards Evolving to Support PGHD Collection and Use?

Technological advancements are enhancing the scope, accuracy, and usability of PGHD. Wearable devices now monitor a wide range of parameters including heart rate, glucose levels, sleep patterns, and activity levels with medical-grade precision. Smartphone applications are allowing users to track medication intake, mood, and dietary habits. Voice recognition tools and smart home devices are also contributing to passive data capture in patient-friendly formats.

To make PGHD clinically relevant, platforms are being developed to integrate this data into electronic health records in structured, interpretable formats. Standardized APIs and data governance frameworks are improving data security, interoperability, and consent management. Clinical algorithms and dashboards are being designed to filter, prioritize, and visualize PGHD for physicians, enabling them to respond to meaningful changes without being overwhelmed by raw data.

Where Is PGHD Adoption Expanding and Which Use Cases Are Leading Application?

PGHD adoption is growing across healthcare systems, wellness programs, remote patient monitoring services, and clinical research. North America and Europe are leading in infrastructure readiness and regulatory support for patient-driven data use. Asia-Pacific is catching up rapidly as wearables and health apps become more affordable and accessible to broad segments of the population.

Use cases are expanding across conditions such as diabetes, cardiovascular disease, mental health, oncology, and respiratory illness. Remote patient monitoring programs rely on PGHD to detect early warning signs and reduce hospital admissions. In clinical trials, patient-reported outcomes and real-time biometrics are improving data accuracy and participant retention. Insurance providers are also utilizing PGHD to tailor wellness incentives and assess risk profiles with greater precision.

Growth in the Patient Generated Health Data market is driven by several factors…

Growth in the patient generated health data market is driven by factors such as rising adoption of wearable technologies, increasing focus on personalized medicine, and growing demand for continuous health monitoring. Advances in sensor miniaturization, mobile connectivity, and health tracking algorithms are enabling reliable, user-friendly data collection across varied demographics.

Regulatory frameworks supporting remote care reimbursement and digital health record integration are encouraging healthcare providers to include PGHD in routine care management. Chronic disease monitoring, post-discharge care, and wellness tracking are creating high-utility application areas for PGHD. Enhanced patient awareness and self-management behaviors are further contributing to data richness, making PGHD a key input for population health analytics, risk stratification, and proactive care delivery models.

SCOPE OF STUDY:

The report analyzes the Patient Generated Health Data market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Data Type (Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data, Other Data Types); End-Use (Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AliveCor Inc.
  • Allscripts Healthcare Solutions
  • Apple Inc.
  • Athenahealth Inc.
  • Cerner Corporation
  • Dexcom Inc.
  • Epic Systems Corporation
  • Fitbit Inc.
  • HealthMine Inc.
  • Livongo Health (now part of Teladoc)
  • Medidata Solutions
  • Medtronic plc
  • Noom Inc.
  • Omada Health Inc.
  • PatientLikeMe
  • Propeller Health
  • WellDoc Inc.
  • Luscii (Omron)
  • Athelas
  • Kwido

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Patient Generated Health Data - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized and Preventive Care Models Spurs Integration of Patient Generated Health Data (PGHD)
    • Expansion of Wearable Devices and Mobile Health Apps Strengthens Data Flow From Patients to Providers
    • Shift Toward Remote Monitoring and Home-Based Care Throws the Spotlight on Real-Time PGHD for Clinical Decision Support
    • Government and Payer Incentives for Chronic Disease Management Encourage Use of PGHD for Outcome-Based Care
    • Advancements in Interoperability and API Integration Improve EMR Compatibility With External Health Data Sources
    • Surge in Consumer Awareness and Digital Health Literacy Supports Active Health Tracking and Data Sharing Behavior
    • Growing Role of AI and Data Analytics Enables Derivation of Actionable Insights From Unstructured PGHD
    • Development of Condition-Specific Tracking Tools Enhances Monitoring of Diabetes, Cardiac Conditions, and Mental Health
    • Patient Empowerment Movements Promote Active Participation in Health Management Through Data Contribution
    • Concerns Over Data Accuracy and Standardization Encourage Investment in Structured Input Tools and Validation Algorithms
    • Integration With Population Health Platforms Enhances Cohort Monitoring and Predictive Modeling
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient Generated Health Data Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Patient Generated Health Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fitness & Wellness Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Fitness & Wellness Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Fitness & Wellness Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disease Management Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disease Management Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Disease Management Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Remote Monitoring Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Remote Monitoring Data by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Remote Monitoring Data by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Data Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Data Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Data Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Patient Generated Health Data by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Patient Generated Health Data by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Patient Generated Health Data by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Patient Generated Health Data by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Patient Generated Health Data by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Patient Generated Health Data Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Patient Generated Health Data by Data Type - Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Patient Generated Health Data by Data Type - Percentage Breakdown of Value Sales for Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data and Other Data Types for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Patient Generated Health Data by End-Use - Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Patient Generated Health Data by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION